Background: Carbapenem resistance among Acinetobacter species has become a life-threatening problem. As a last resort in the treatment of gram-negative bacteria infection, resistance to colistin is also a serious problem. The aim of study was to analyze the mechanism of resistance and perform genotyping of carbapenem-resistant Acinetobacter from clinical infection and fecal survey samples in Southern China.
Background
Acinetobacter species are a heterogeneous group of strictly aerobic, non-motile gram-negative, nonfermenting encapsulated coccobacilli that can be found in the environment [1, 2] . Among them, Acinetobacter baumannii has become a major cause of nosocomial infections in recent years. A. baumannii is a conditional pathogen, especially when the resistance of inpatients declines; A. baumannii can invade the human body in various ways and cause fatal infection [3, 4] . Meanwhile, infection caused by Acinetobacter species other than A. baumannii has caused concern recently [5] . Moreover, the developed resistance of Acinetobacter to a variety of commonly used antimicrobials has led to ineffective antibiotics and increased mortality following infection [6] . Carbapenems are commonly used to treat infections caused by Acinetobacter species; an outbreak of carbapenem-resistant Acinetobacter species can complicate therapy and may lead to treatment failure [7, 8] .
There are three main mechanisms that Acinetobacter species use to resist carbapenems: production of enzymes (e.g., carbapenemase) that are capable of hydrolyzing carbapenems; altered function of membraneassociated proteins such as porins; and activation of drug efflux pumps [9] . Carbapenemases that have been reported in Acinetobacter species include Ambler class B metallo-β-lactamases, such as IMP and VIM, and the recently described NDM; Ambler class D oxacillinases (OXAs); and Ambler class A β-lactamases [10, 11] . The OXA carbapenemase genes of Acinetobacter species are divided into some phylogenetic subgroups: bla OXA-23-like , bla OXA-24/40-like , bla OXA-51-like , bla OXA-58-like , bla OXA-143-like , and bla OXA-235-like . Although OXA carbapenemase weakly hydrolyze carbapenems, they can confer higher resistance when bla OXA genes are overexpressed using a strong promoter with mobile insertion elements such as ISAba1 [12, 13] . Low outer membrane permeability, due to changes in the primary structure or loss of carbapenem-associated outer membrane protein (carO), a 25/29-kDa outer-membrane protein, is one of the best-characterized mechanisms of intrinsic carbapenem resistance in Acinetobacter species [14, 15] . Drug efflux pumps are most often associated with carbapenem resistance in Acinetobacter species when overexpressed; the resistance-nodulation-division (RND)-type family is of particular clinical importance [16] . To date, five RND efflux pumps have been described in Acinetobacter species: AdeABC, AdeDE, AdeIJK, AdeXYZ, and AdeFGH [17] .
Colistin has been used in veterinary and human medicine for over 50 years. Colistin has broad-spectrum activities against gram-negative bacteria, but is associated with both nephrotoxicity and neurotoxicity, limiting its clinical application. However, colistin has now emerged as an effective therapeutic against carbapenem-resistant bacteria. Now, over-reliance on colistin to treat these diseases has led to the development of resistance to colistin [18] ; thus, exploring the resistance mechanism of Acinetobacter species will be important.
Mcr, a plasmid-mediated colistin resistance gene first reported in 2015 in China [19] , has increased our knowledge of colistin-resistance mechanisms other than chromosomal mechanisms. The plasmid-borne colistinresistance gene mcr can also be transmitted and transferred by mobile genetic components [20] .
Mobile genetic elements, such as integrons, transposons, and insertion sequences, provide bacteria with a powerful genetic toolbox, which could lead to multidrug-resistant (MDR) strains. Transfer of mobile genetic elements between different isolates, even in different species, has also been described in Acinetobacter [21, 22] .
Various bacteria, including MDR bacteria, are contained in the gut microbiota, which serves as an important and large reservoir of resistance genes. Fecal samples might therefore be the ideal specimen for studying and detecting antimicrobial-resistant genes. Several studies have reported high rates of fecal carriage for Acinetobacter, making the digestive tract a potential reservoir for nosocomial infections and outbreaks [23] . The aim of this study was to analyze the mechanism of resistance and perform genotyping of carbapenem-resistant Acinetobacter from clinical infection and fecal survey samples in Southern China.
Methods

Bacterial isolates and species identification
Between January 2014 and December 2015, 170 nonduplicate carbapenem-resistant Acinetobacter isolates were obtained from clinical infection samples (including sputum, puncture fluid, urine, instrument, blood) which were collected from Nanfang Hospital, a large general and teaching hospital in Guangzhou, China.
Moreover, 5000 fecal survey samples were collected from July 2014 to June 2015, followed by incubation on MacConkey agar plates with 2 μg/mL meropenem. A total of 434 g-negative carbapenem-resistant isolates were collected. The recA [24] gene was amplified from non-fermenting isolates and used as a control for the genus Acinetobacter. Finally, 74 carbapenem-resistant Acinetobacter species were obtained. The study was approved by the Medical Ethics Committee of Nanfang Hospital Southern Medical University and conducted in compliance with the Declaration of Helsinki.
All isolates were confirmed as Acinetobacter species by biochemical methods, the recA gene, and analysis of 16S ribosomal RNA (rRNA) sequences. The Acinetobacter calcoaceticus-A. baumannii complex was confirmed by 16-23S rRNA and internal transcribed spacer sequences [25] .
Antimicrobial susceptibility testing
Analysis of susceptibility to antimicrobial compounds was performed using the automated BD Phoenix 100 Microbiology System (Becton Dickinson and Co., Franklin Lakes, NJ, USA) according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI) M100-S27 criteria. The antibiotics tested were ampicillin, ampicillin-sulbactam, amoxicillin-clavulanic acid, piperacillin, piperacillin-tazobactam (4 mg/L tazobactam), ceftazidime, cefotaxime, cefazolin, cefepime, imipenem, meropenem, aztreonam, chloramphenicol, levofloxacin, ciprofloxacin, gentamicin, tetracycline, colistin, trimethoprim-sulfamethoxazole, and amikacin. Escherichia coli ATCC 25922 and Pseudomonas aeruginosa ATCC 27853 were used as control strains for antimicrobial susceptibility testing.
Molecular detection of resistance genes
DNA was extracted using the AccuPrep® genomic DNA extraction kit according to the manufacturer's instructions. PCR was performed for antibiotic resistancerelated genes described below.
The following carbapenemase-encoding genes were detected: class A β-lactamases genes: bla KPC [26] ; class B metallo-β-lactamases genes: bla IMP [26] , bla VIM [26] , bla SPM [26] , and bla NDM [26] ; and class D oxacillinases genes: bla OXA-23-like [27] , bla OXA-24/40-like [27] , bla OXA-51-like [27] , and bla OXA-58-like [27] . The colistinrelated resistance gene: mcr-1 [28] , mcr-2 [28] , mcr-3 [28] , mcr-4 [28] , and mcr-5 [28] . The protein-related gene carO [29] (A. baumannii outer membrane protein involved in carbapenem resistance) and the drug efflux pump component-related genes adeA [30] , adeB [31] , adeC [31] , adeI [31] , adeJ [31] , and adeK [31] were also detected.
Database searches for DNA sequence similarities were performed using BLAST (https://blast.ncbi.nlm.nih.gov). The construction of a carO phylogenetic tree was obtained by MEGA using the neighbor-joining method. A model of the p-distance was used to estimate distances for nucleotide sequences. The significance of the groups observed in constructed trees was determined by bootstrap analysis with 1000 replicates.
Mobile genetic element-related resistance genes, including integrons (intI1 [32, 33] , intI2 [32, 34] , intI3 [32] ), transposons (tnpU [35] and tnp513 [35] ), the variable region of class 1 integron and class 2 integron, and insertion sequences (IS26 [36] , ISAba1 [37] , and ISAba125 [37] ) were also analyzed. The PCR cycle consisted of denaturation at 94°C for 5 min, followed by 35 cycles of 30 s at 94°C, annealing for 40 s at optimal annealing temperature, and extension at 72°C for 40 s for the genes and 4 min for the variable region of intI1 and intI2.
The primers used for PCR are shown in Table 1 . Primer synthesis and sequencing of PCR products were performed by Sangon Biotech Co., Ltd. (Shanghai, China).
Eric-PCR
Enterobacterial Repetitive Intergenic Consensus (ERIC-PCR) was performed on all isolates depending on the different species [38] . Band comparisons were performed by clustering analysis based on the unweighted pairgroup method with arithmetic mean of isolates using Quantity One-v4.6.7.
Results
Identification of isolates
During the study period, 244 (170 from clinical infection samples and 74 from fecal survey samples) carbapenemresistant Acinetobacter species were collected. PCR amplification of the recA gene of all strains was positive. Further identification revealed 181 A. baumannii and 63 non-baumannii Acinetobacter species. Remarkably, clinical infection samples and fecal survey samples exhibited large differences in species (Table 2) . Acinetobacter baumannii was the predominant clinical carbapenemresistant bacteria (97.1%). However, 58 carbapenemresistant non-baumannii Acinetobacter were isolated in fecal survey samples, and 77.59% were further identified as A. junni.
Antimicrobial susceptibility testing
According to the minimal inhibitory concentration (MIC) values of tested antibiotics (Table 3 and Additional file 1: Table S1), the MIC breakpoints of A. baumannii complex to colistin refer to the CLSI standard, and the MIC breakpoints of non-baumannii Acinetobacter to colistin refer to the EUCAST standard, because the CLSI standard was applicable to A. baumannii complex only. All isolates were resistant to carbapenems and cephems, including cefazolin, ceftazidime, and cefepime, and sensitivity to amikacin and colistin was observed in 32.80 and 97.10% of the isolates, respectively. However, non-baumannii Acinetobacter was more sensitive to amikacin than Acinetobacter baumannii. Six non-baumannii Acinetobacter and one Acinetobacter baumannii were resistant to colistin. Notably, all of the carbapenem-resistant Acinetobacter isolates were MDR (Table 3 ) [39] .
Molecular detection of resistance genes
Carbapenemase-encoding genes
The prevalence of bla OXA-23-like , bla OXA-24/40-like , bla OXA-51-like , and bla OXA-58-like gene occurrences were 71.31, 2.45, 75.00, and 12.30%, respectively. Co-existence of the bla OXA-23-like and bla OXA-51-like genes was detected Class B metallob-β-lactamases bla IMP GGA ATA GAG TGG CTT AAY TCT C GGT TTA AYA AAA CAA CCA CC 232 50 [25] bla VIM GAT GGT GTT TGG TCG CAT A CGA ATG CGC AGC ACC AG 390 58 [25] bla SPM AAA ATC TGG GTA CGC AAA CG ACA TTA TCC GCT GGA ACA GG 271 55 [25] bla NDM GGT TTG GCG ATC TGG TTT TC CGG AAT GGC TCA TCA CGA TC 621 60 [25] class D oxacillinases bla OXA-23-like GAT CGG ATT GGA GAA CCA GA ATT TCT GAC CGC ATT TCC AT 501 53 [26] bla OXA-24-like GGT TAG TTG GCC CCC TTA AA AGT TGA GCG AAA AGG GGA TT 246 53 [26] bla OXA-51-like TAA TGC TTT GAT CGG CCT TG TGG ATT GCA CTT CAT CTT GG 353 54 [26] bla OXA-58-like AAG TAT TGG GGC TTG TGC TG CCC CTC TGC GCT CTA CAT AC 599 54 [26] Colistin-related resistance gene mcr-1 AGTCCGTTTGTTCTTGTGGC AGATCCTTGGTCTCGGCTTG 320 58 [27] mcr-2 CAAGTGTGTTGGTCGCAGTT TCTAGCCCGACAAGCATACC 715 58 [27] mcr-3 AAATAAAAATTGTTCCGCTTATG AATGGAGATCCCCGTTTTT 929 58 [27] mcr-4 TCACTTTCATCACTGCGTTG TTGGTCCATGACTACCAATG 1116 58 [27] mcr-5 ATGCGGTTGTCTGCATTTATC TCATTGTGGTTGTCCTTTTCTG 1644 58 [27] porins carO ATT GTA GAA AGC TGA GAC AT ATT TCT YTA TGC TCA CCT GA variable a 50 [28] drug efflux pumps adeA GCTGAGCCACCACCGGCTAAAG ACCTTCAACAACGACTCTGTCACC 990 56 [29] adeB CTTGCATTTACGTGTGGTGT GCTTTTCTACTGCACCCAAA 168 54 [30] adeC CCCAACCATTGGTGTAACG GAACATCCGTGCTTTAGC 626 52 [30] adeI CAAATGCAAATGTAGATCTTGG AAACTGCCTTTACTTAGTTG 210 51 [30] adeJ GGTCATTAATATCTTTGGC GGTACGAATACCGCTGTCA 221 55 [30] adeK TTGATAGTTACTTGACTGTTC GGTTGGTGAACCACTGTATC 162 51 [30] integrase intI1 GCA TCC TCG GTT TTC TGG GGT GTG GCG GGC TTC GTG 457 60 [32] variable region GGCATCCAAGCAGCAAG AAGCAGACTTGACCTGA variable 52 [33] intI2 CAC GGA TAT GCG ACA AAA AGG T GTA GCA AAC GAG TGA CGA AAT G 789 54 [32] variable region GTAGCAAACGAGTGACGAAATG GAATTCGACATGTTTGGACGCCTTGGC variable 52 [33] intI3 ATC TGC CAA ACC TGA CTG CGA ATG CCC CAA CAA CTC 922 60 [32] transposon tnpU CCAACTGATGGCGGTGCCTT CGGTATGGTGGCTTTCGC 403 59 [35] tnp513 ATGTCGCTGGCAAGGAACGC GGGTTCGCTGCGAGGATTGT 240 59 [35] Insertion sequence IS26 AGCGGTAAATCGTGGAGTGA CAAAGTTAGCGATGAGGCAG 619 58 [36] in 171 strains. It is notable that three strains simultaneously carried the genes bla OXA-23-like , bla OXA-51-like , and bla OXA-58-like . With regard to the 181 isolates of A. baumannii, 179 (98.90%) strains carried the bla OXA-51-like gene, which is characteristic of A. baumannii. For other carbapenemase genes in all strains, 2 (0.82%) were positive for the bla IMP gene, 4 (1.64%) for the bla VIM gene, and 57 (23.36%) for the bla NDM gene. It is remarkable that all bla NDM -positive strains were isolated from fecal survey samples, while 41 strains possessed bla NDM-1, 12 strains possessed bla NDM-5 , and 4 strains possessed bla NDM-4 . The genes bla KPC and bla SPM were not identified.
Colistin-related resistant genes
Six (8.70%) non-baumannii Acinetobacter and one (0.55%) A. baumannii isolate was resistant to colistin, while five non-baumannii Acinetobacter strains from fecal samples tested positive for the mcr-1 gene.
Protein-related genes
The carO gene was detected in 164 (67.21%) strains, and an analysis of 164 complete carO porin nucleotide sequences was performed. All strains showed amplified products of approximately 1200 bp, with the exception of A. baumannii 100588A and 513,007, in which a band of approximately 2000 bp was amplified and the distal part of the insertion (from 1066 to 2259 of the sequence) showed 100% identity with a fragment from A. baumannii BJAB0715 (GenBank accession number CP003847.1, position 2960028 to 2961220). Acinetobacter sp. 1029087 (GenBank accession number KX517470.1) contained an insertion of 2 bp (starting at +230 of the carO gene), which generated a stop codon (TAA) at position 247-249 in the nucleotide sequence of the carO gene. Sequencing of carO genes revealed the presence of 11 distinct variants; 10 novel sequences were discovered, which were designated as different if they had at least one nucleotide change. The dominant sequence was 99-100% identical to A. baumannii strain 3027STDY5784958 (Gen-Bank accession number LT594095.1) and the ten novel sequences exhibited 92-99% identity with sequences in the database. The novel sequences were a result of deletions, insertions, or point mutations. Phylogenetic analysis of the detected carO gene showed that all sequences were classified into two groups (Fig. 1) .
Drug efflux pump component-related genes
Efflux system genes were present in approximately 70% of isolates, and adeABC and adeIJK were observed in 76.23 and 72.13%, respectively.
Mobile genetic element-related resistance genes
Multidrug resistance to aminoglycosides, quinolones, tetracycline, and trimethoprim-sulfamethoxazole antimicrobial agents might be a result of the presence of a high rate of mobile genetic elements, including IS26 (97.54%), ISAba1 (90.16%), ISAba125 (93.44%), tnpU (63.52%), and tnp513 (68.03%). Class 1 and 2 integrons were detected in 180 (73.77%) and 5 (2.05%) strains, respectively, while class 3 integrons were absent. The amplicons ranged in size from 1.5 to 2.6 kb. A single band was obtained in 177 isolates and two bands were obtained in three isolates. Sequencing results revealed that the variant region of class 1 integron has four distinct gene cassettes (aadA1-catB8-aacA4, aacC1-OrfA-OrfB-aadA1, dfrA17-aadA5, aadA2-orfF-dfrA12), and the variant region of the class 2 integron has one gene cassette (dfrA1-sat2-aadA1-orfX) ( Table 4) .
Eric-PCR
Genotyping by ERIC-PCR demonstrated a high genetic diversity of non-baumannii Acinetobacter in different samples, and one was selected as a representative of the same band for dendrogram cluster analysis (Fig. 2) . However, A. baumannii detected in clinical samples had greater than 90% similarity, suggesting they may have originated from the same clone. ISAba125 GGGTAATGCTCGTATCGT TAGACGTAGACGTGGTCA 184 51 [37] a The forward primer hybridizes to a region located 294 bp upstream of the 5′ end of the carO initiation codon, while the reverse primer anneals to a sequence located 131 bp downstream of the carO termination codon 
Discussion
The results of the carbapenem resistance gene sequencing showed that the bla NDM gene was detected in 57 isolates and only present in the fecal survey samples. Fu et al. [40, 41] described that among Acinetobacter species, the bla NDM gene is widely disseminated in China. It is possible that the spread of New Delhi metallo-betalactamase-1(NDM-1) carbapenemases may occur rapidly through Acinetobacter spp. because it may become markedly more difficult to eradicate [42] and has begun to steadily express NDM [43] . We showed that 98.90% of the A. baumannii isolates contained the bla OXA-51-like gene. The results of Lowings et al. [44] and Correa et al. [45] indicated that 99 and 97.5% of the A. baumannii isolates contained this gene. Zhao et al. [46] showed 91.7% of the A. baumannii Table 3 Susceptibilities of Acinetobacter species and the distribution of resistant genes among these species [51] , these data indicated that the prevalence or predominance of some OXA subgroups depends on geographic/regional variations.
In the present study, six (8.70%) non-baumannii Acinetobacter and one (0.55%) A. baumannii isolates were resistant to colistin. In 74 fecal survey samples, we detected that five colistin-resistant A. junii were positive for the mcr-1 gene, and the mcr gene in Acinetobacter isolated from human samples had not been reported in the literature thus far. Moreover, all three A. junii (C1121030, C1121090, C1121152) contained bla OXA-58-like and bla NDM , one of the three strains contained bla NDM , bla VIM , bla OXA-58-like , and mcr-1, while the remaining strains contained bla NDM , bla IMP , bla OXA-58-like , and mcr-1. This is the first report of more than two carbapenem resistance genes coexisting with the mcr-1 gene in Acinetobacter species.
In the 74 fecal survey samples, 57 bla NDM genes were detected; the mcr-1 gene was detected in five isolates, and co-existed with carbapenem resistance genes. In 174 clinical infection samples, both the bla NDM and mcr-1 genes were absent, and no more than two carbapenemase genes co-existed. Comparison of clinical infection samples and fecal survey samples revealed that the detection rate of carbapenem resistance and mcr-1 genes was higher in fecal survey samples, and the strains in which multiple MDR genes co-existed were all isolated from fecal samples, which may indicate that the intestinal tract is an important place for the transfer of bacterial resistance, reminding us of the importance to control nosocomial infections.
We observed a high mutation rate in the porin carO gene. The sequencing of carO genes revealed the presence of 11 distinct variants and 10 novel sequences. We analyzed the homology of carO gene in carbapenemresistant Acinetobacter and carbapenem-sensitive reference strain ATCC 17978. The resulting nucleotide sequence and amino acid sequence exhibited 90 and 91% identity, respectively, with the carO sequence of ATCC 17978. When we compared these sequences with those available in different databanks (sequences from NCBI databanks), we identified a non-variable Nterminal domain (1-131) and two variable domains (132-162 and 200-238) by comparing amino acid sequences (Additional file 2: Figure S1 ), and two variable domains (397-480 and 588-677) by comparing nucleotide sequences (Additional file 3: Figure S2 ). We speculate that the structure and function of protein CarO will have considerable variation due to the presence of these two variable domains. The phenomenon of CarO participates in carbapenem influx has been reported, changes in the amino acid composition of CarO that could lead to altered porin may result in carbapenem resistance [17] , although this will require further verification.
Many studies have described the harboring of the AdeABC efflux system in clinical isolates of A. baumannii [4] . Some studies have suggested that these genes are only present in MDR isolates while some studies have reported them in MDR and non-MDR isolates [52, 53] . Here, we report that the presence of adeABC and adeIJK in A. baumannii was 96.13 and 92.27%, but 12.77 and 2.13% in A. junii, respectively. Sirawit et al. [53] showed that the MDR phenotype in most A. baumannii isolates was associated with efflux pumps. AdeIJK expression was most common (97%), and 52% of the A. baumannii isolates simultaneously produced up to three RND-type efflux systems. Yoon et al. [54] detected the AdeB gene in 13 (92.86%) clinical isolates and AdeG and intrinsic AdeJ in all clinical isolates of A. baumannii. This is consistent with other studies [17] , suggesting that efflux systems are likely species-specific. Overexpression of these pumps in response to antibiotic exposure leads to decreased susceptibility to the antibiotics [55] .
A. baumannii was primarily isolated from clinical infection samples, and non-baumannii Acinetobacter was primarily isolated from fecal survey samples. ERIC-PCR demonstrated a high genetic diversity of non-baumannii 
